A detailed history of Retirement Guys Formula LLC transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Retirement Guys Formula LLC holds 63,817 shares of GALT stock, worth $58,711. This represents 0.08% of its overall portfolio holdings.

Number of Shares
63,817
Previous 41,157 55.06%
Holding current value
$58,711
Previous $93,000 88.17%
% of portfolio
0.08%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$2.04 - $2.86 $46,226 - $64,807
22,660 Added 55.06%
63,817 $175,000
Q2 2024

Aug 01, 2024

BUY
$2.13 - $4.2 $15,815 - $31,185
7,425 Added 22.01%
41,157 $93,000
Q1 2024

Apr 19, 2024

BUY
$1.6 - $2.44 $19,571 - $29,846
12,232 Added 56.89%
33,732 $80,000
Q4 2023

Jan 22, 2024

BUY
$1.6 - $2.18 $16,000 - $21,800
10,000 Added 86.96%
21,500 $35,000
Q3 2023

Oct 13, 2023

BUY
$1.38 - $1.97 $15,869 - $22,655
11,500 New
11,500 $22,000

Others Institutions Holding GALT

About GALECTIN THERAPEUTICS INC


  • Ticker GALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,426,000
  • Market Cap $54.7M
  • Description
  • Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...
More about GALT
Track This Portfolio

Track Retirement Guys Formula LLC Portfolio

Follow Retirement Guys Formula LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Guys Formula LLC, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Guys Formula LLC with notifications on news.